MetLife Investment Advisors »

Heron Therapeutics shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $91k 54k 1.70
2023-09-30 $55k 54k 1.03
2023-06-30 $62k 54k 1.16
2023-03-31 $81k 54k 1.51
2022-12-31 $134k 54k 2.50
2022-09-30 $226k 54k 4.22
2022-06-30 $149k 54k 2.79
2022-03-31 $306k 54k 5.72
2021-12-31 $299k 33k 9.13
2021-09-30 $350k 33k 10.69
2021-06-30 $509k 33k 15.52
2021-03-31 $531k 33k 16.21
2020-12-31 $827k 39k 21.17
2020-09-30 $579k 39k 14.82
2020-06-30 $575k 39k 14.72
2020-03-31 $429k 37k 11.74
2019-12-31 $859k 37k 23.50
2019-09-30 $626k 34k 18.50
2019-06-30 $546k 29k 18.59
2019-03-31 $718k 29k 24.44
2018-12-31 $762k 29k 25.94
2018-09-30 $1.5M 47k 31.66
2018-06-30 $1.1M 29k 38.85
2018-03-31 $689k 25k 27.59
2017-12-31 $399k 22k 18.10